跳至主要内容
临床试验/EUCTR2008-001620-31-GB
EUCTR2008-001620-31-GB进行中(未招募)不适用

Glutathione Status in Platelets From Patients With Type 2 Diabetes: Therapeutic Potential of N-acetylcysteine to Help Prevent Platelet Hyperaggregability - NAC study

HS Highland0 个研究点目标入组 44 人开始时间: 2009年8月21日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Men or post menopausal women with type 2 diabetes
  • Not recieving aspirin (group A)
  • Receiving Aspirin (Group B)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Very poorly controlled diabetes (HbA1c > 10%)
  • Significant hypertriglyceridaemia (TG > 4 mmol/L)
  • Renal disease (creatinine > 150 umol/L)
  • Current or recently stopped smokers (< 6 months)
  • Patients receiving other anti platelet therapy (i.e. clopidogrel, dipyridamole), or lipid lowering therapy where the patients are unable or unwilling to stop therapy for the duration of study participation.
  • Patients with asthma
  • Current use of tetracycline antibiotics or cough suppressants

研究者

发起方
HS Highland

相似试验